Form 4: Organon & Co. Executive Exercises Stock Options and Sells Shares

Juan Camilo Arjona Ferreira, Head of R&D & CMO at Organon & Co., exercised restricted stock units and sold a portion of the acquired shares on August 11, 2024.

Summary

• On August 11, 2024, Juan Camilo Arjona Ferreira, Head of R&D & CMO at Organon & Co., exercised 11,519 restricted stock units, each representing a contingent right to receive one share of Organon common stock.
• Following the exercise, Arjona Ferreira sold 3,991 shares of common stock at a price of $20.15 per share.
• The transactions resulted in Arjona Ferreira beneficially owning 7,541.355 shares of Organon common stock directly.
• Arjona Ferreira continues to hold 23,038 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. The sentiment is neutral as it doesn't inherently indicate positive or negative performance for the company.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The sale of shares by a company executive could be perceived differently by stakeholders.
• Some may view it as a lack of confidence in the company's future, while others may see it as a normal part of personal financial planning.

Key Dates